A detailed history of State Of Wisconsin Investment Board transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 67,768 shares of ARWR stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,768
Previous 71,630 5.39%
Holding current value
$1.33 Million
Previous $1.86 Million 29.55%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.36 - $29.54 $74,768 - $114,083
-3,862 Reduced 5.39%
67,768 $1.31 Million
Q2 2024

Aug 14, 2024

SELL
$21.87 - $28.24 $87,392 - $112,847
-3,996 Reduced 5.28%
71,630 $1.86 Million
Q1 2024

May 14, 2024

SELL
$27.21 - $39.48 $214,251 - $310,865
-7,874 Reduced 9.43%
75,626 $2.16 Million
Q4 2023

Feb 12, 2024

SELL
$21.2 - $31.03 $39,622 - $57,995
-1,869 Reduced 2.19%
83,500 $2.56 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $76,530 - $105,389
-2,921 Reduced 3.31%
85,369 $2.29 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $119,610 - $196,720
-4,754 Reduced 5.11%
88,290 $3.15 Million
Q1 2023

May 15, 2023

SELL
$23.68 - $38.51 $184,538 - $300,108
-7,793 Reduced 7.73%
93,044 $2.36 Million
Q4 2022

Feb 14, 2023

SELL
$28.0 - $40.56 $47,292 - $68,505
-1,689 Reduced 1.65%
100,837 $4.09 Million
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $156,890 - $255,801
-5,295 Reduced 4.91%
102,526 $3.39 Million
Q2 2022

Aug 15, 2022

SELL
$27.79 - $50.61 $777,536 - $1.42 Million
-27,979 Reduced 20.6%
107,821 $3.8 Million
Q4 2021

Feb 11, 2022

SELL
$58.09 - $82.51 $23,236 - $33,004
-400 Reduced 0.29%
135,800 $9 Million
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $81,732 - $118,943
1,400 Added 1.04%
136,200 $8.5 Million
Q2 2021

Aug 12, 2021

SELL
$62.15 - $90.32 $186,450 - $270,960
-3,000 Reduced 2.18%
134,800 $11.2 Million
Q1 2021

May 17, 2021

SELL
$61.35 - $90.47 $177,915 - $262,363
-2,900 Reduced 2.06%
137,800 $9.14 Million
Q4 2020

Feb 03, 2021

SELL
$43.82 - $85.37 $889,546 - $1.73 Million
-20,300 Reduced 12.61%
140,700 $10.8 Million
Q2 2020

Aug 12, 2020

BUY
$26.12 - $43.27 $167,168 - $276,928
6,400 Added 4.14%
161,000 $6.95 Million
Q1 2020

May 06, 2020

BUY
$20.56 - $63.12 $308,400 - $946,800
15,000 Added 10.74%
154,600 $4.45 Million
Q3 2019

Nov 12, 2019

BUY
$26.26 - $34.86 $91,910 - $122,010
3,500 Added 2.57%
139,600 $3.93 Million
Q2 2019

Aug 14, 2019

BUY
$17.43 - $28.82 $244,020 - $403,480
14,000 Added 11.47%
136,100 $3.61 Million
Q1 2019

May 13, 2019

BUY
$12.05 - $20.18 $386,805 - $647,778
32,100 Added 35.67%
122,100 $2.24 Million
Q4 2018

Feb 11, 2019

BUY
$10.74 - $19.7 $13,962 - $25,610
1,300 Added 1.47%
90,000 $1.12 Million
Q2 2018

Aug 03, 2018

BUY
$6.37 - $14.02 $565,019 - $1.24 Million
88,700 New
88,700 $1.21 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.